Annual CFO
-$128.51 M
-$58.21 M-82.79%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual cash flow from operations is -$128.51 million, with the most recent change of -$58.21 million (-82.79%) on December 31, 2023.
- During the last 3 years, AVDL annual CFO has fallen by -$79.78 million (-163.70%).
- AVDL annual CFO is now -252.46% below its all-time high of $84.29 million, reached on December 31, 2015.
Performance
AVDL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$6.89 M
+$11.30 M+62.11%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly cash flow from operations is -$6.89 million, with the most recent change of +$11.30 million (+62.11%) on September 30, 2024.
- Over the past year, AVDL quarterly CFO has increased by +$21.14 million (+75.42%).
- AVDL quarterly CFO is now -126.10% below its all-time high of $26.40 million, reached on December 31, 2015.
Performance
AVDL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$82.81 M
+$31.34 M+27.45%
September 30, 2024
Summary
- As of February 20, 2025, AVDL TTM cash flow from operations is -$82.81 million, with the most recent change of +$31.34 million (+27.45%) on September 30, 2024.
- Over the past year, AVDL TTM CFO has increased by +$45.70 million (+35.56%).
- AVDL TTM CFO is now -198.24% below its all-time high of $84.29 million, reached on December 31, 2015.
Performance
AVDL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AVDL Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -82.8% | +75.4% | +35.6% |
| 3 y3 years | -163.7% | +78.5% | +1.9% |
| 5 y5 years | -55.4% | +78.5% | +1.9% |
AVDL Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -82.8% | at low | -1.3% | +82.0% | -24.5% | +35.6% |
| 5 y | 5-year | -235.3% | at low | -1.3% | +82.0% | -188.0% | +35.6% |
| alltime | all time | -252.5% | at low | -126.1% | +82.0% | -198.2% | +35.6% |
Avadel Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.89 M(-62.1%) | -$82.81 M(-27.5%) |
| Jun 2024 | - | -$18.19 M(-38.8%) | -$114.14 M(-10.8%) |
| Mar 2024 | - | -$29.70 M(+6.0%) | -$127.98 M(-0.4%) |
| Dec 2023 | -$128.51 M(+82.8%) | -$28.03 M(-26.7%) | -$128.51 M(+10.9%) |
| Sep 2023 | - | -$38.23 M(+19.4%) | -$115.85 M(+37.2%) |
| Jun 2023 | - | -$32.02 M(+5.9%) | -$84.42 M(+27.0%) |
| Mar 2023 | - | -$30.23 M(+96.8%) | -$66.49 M(-5.4%) |
| Dec 2022 | -$70.30 M(-9.1%) | -$15.37 M(+125.9%) | -$70.30 M(-9.2%) |
| Sep 2022 | - | -$6.80 M(-51.7%) | -$77.44 M(-15.7%) |
| Jun 2022 | - | -$14.09 M(-58.6%) | -$91.88 M(+4.5%) |
| Mar 2022 | - | -$34.05 M(+51.3%) | -$87.94 M(+13.8%) |
| Dec 2021 | -$77.31 M(+58.6%) | -$22.51 M(+6.0%) | -$77.31 M(+4.6%) |
| Sep 2021 | - | -$21.24 M(+109.2%) | -$73.93 M(+17.6%) |
| Jun 2021 | - | -$10.15 M(-56.6%) | -$62.88 M(+3.9%) |
| Mar 2021 | - | -$23.41 M(+22.4%) | -$60.51 M(+24.2%) |
| Dec 2020 | -$48.73 M(+27.2%) | -$19.13 M(+87.6%) | -$48.73 M(+28.7%) |
| Sep 2020 | - | -$10.19 M(+31.0%) | -$37.86 M(+7.9%) |
| Jun 2020 | - | -$7.78 M(-33.1%) | -$35.09 M(+22.0%) |
| Mar 2020 | - | -$11.64 M(+41.0%) | -$28.75 M(-25.0%) |
| Dec 2019 | -$38.33 M(-53.7%) | -$8.25 M(+11.2%) | -$38.33 M(-29.8%) |
| Sep 2019 | - | -$7.42 M(+412.7%) | -$54.60 M(-19.0%) |
| Jun 2019 | - | -$1.45 M(-93.2%) | -$67.43 M(-21.5%) |
| Mar 2019 | - | -$21.21 M(-13.5%) | -$85.91 M(+3.9%) |
| Dec 2018 | -$82.72 M(-596.4%) | -$24.53 M(+21.1%) | -$82.72 M(+14.9%) |
| Sep 2018 | - | -$20.25 M(+1.6%) | -$72.01 M(+31.4%) |
| Jun 2018 | - | -$19.93 M(+10.7%) | -$54.82 M(+105.7%) |
| Mar 2018 | - | -$18.01 M(+30.3%) | -$26.65 M(-260.0%) |
| Dec 2017 | $16.66 M(-11.8%) | -$13.82 M(+351.8%) | $16.66 M(-56.4%) |
| Sep 2017 | - | -$3.06 M(-137.2%) | $38.22 M(+4.7%) |
| Jun 2017 | - | $8.23 M(-67.5%) | $36.52 M(+53.2%) |
| Mar 2017 | - | $25.31 M(+226.9%) | $23.84 M(+26.1%) |
| Dec 2016 | $18.90 M(-77.6%) | $7.74 M(-262.6%) | $18.90 M(-49.7%) |
| Sep 2016 | - | -$4.76 M(+7.0%) | $37.56 M(-38.3%) |
| Jun 2016 | - | -$4.45 M(-121.8%) | $60.91 M(-23.3%) |
| Mar 2016 | - | $20.37 M(-22.8%) | $79.39 M(-5.8%) |
| Dec 2015 | $84.29 M(-893.9%) | $26.40 M(+42.0%) | $84.29 M(+63.4%) |
| Sep 2015 | - | $18.59 M(+32.6%) | $51.58 M(+41.4%) |
| Jun 2015 | - | $14.03 M(-44.5%) | $36.49 M(+113.9%) |
| Mar 2015 | - | $25.27 M(-500.5%) | $17.06 M(-260.6%) |
| Dec 2014 | -$10.62 M(-48.7%) | -$6.31 M(-280.5%) | -$10.62 M(-6.2%) |
| Sep 2014 | - | $3.50 M(-164.7%) | -$11.32 M(-24.6%) |
| Jun 2014 | - | -$5.41 M(+125.4%) | -$15.02 M(-3.0%) |
| Mar 2014 | - | -$2.40 M(-65.8%) | -$15.48 M(-25.1%) |
| Dec 2013 | -$20.68 M(-10.6%) | -$7.02 M(+3480.6%) | -$20.68 M(+4.0%) |
| Sep 2013 | - | -$196.00 K(-96.7%) | -$19.88 M(-21.5%) |
| Jun 2013 | - | -$5.86 M(-22.8%) | -$25.33 M(-3.1%) |
| Mar 2013 | - | -$7.60 M(+22.2%) | -$26.15 M(+13.0%) |
| Dec 2012 | -$23.14 M | -$6.22 M(+10.1%) | -$23.14 M(+12.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | -$5.65 M(-15.5%) | -$20.64 M(+22.7%) |
| Jun 2012 | - | -$6.69 M(+45.8%) | -$16.82 M(+59.0%) |
| Mar 2012 | - | -$4.58 M(+23.2%) | -$10.58 M(+2.5%) |
| Dec 2011 | -$10.32 M(+89.2%) | -$3.72 M(+103.6%) | -$10.32 M(+56.1%) |
| Sep 2011 | - | -$1.83 M(+311.7%) | -$6.61 M(-26.9%) |
| Jun 2011 | - | -$444.00 K(-89.7%) | -$9.05 M(+42.0%) |
| Mar 2011 | - | -$4.33 M(>+9900.0%) | -$6.37 M(+16.7%) |
| Dec 2010 | -$5.46 M(-166.6%) | -$12.00 K(-99.7%) | -$5.46 M(-50.2%) |
| Sep 2010 | - | -$4.26 M(-290.8%) | -$10.96 M(+124.8%) |
| Jun 2010 | - | $2.23 M(-165.4%) | -$4.88 M(+53.9%) |
| Mar 2010 | - | -$3.42 M(-38.1%) | -$3.17 M(-138.7%) |
| Dec 2009 | $8.20 M(-209.2%) | -$5.51 M(-403.0%) | $8.20 M(-25.7%) |
| Sep 2009 | - | $1.82 M(-53.8%) | $11.03 M(-10.6%) |
| Jun 2009 | - | $3.94 M(-50.4%) | $12.34 M(+222.8%) |
| Mar 2009 | - | $7.95 M(-396.2%) | $3.82 M(-150.9%) |
| Dec 2008 | -$7.51 M(-61.0%) | -$2.68 M(-185.7%) | -$7.51 M(+16.2%) |
| Sep 2008 | - | $3.13 M(-168.5%) | -$6.46 M(-50.0%) |
| Jun 2008 | - | -$4.57 M(+35.1%) | -$12.91 M(-14.7%) |
| Mar 2008 | - | -$3.38 M(+107.0%) | -$15.14 M(-21.3%) |
| Dec 2007 | -$19.24 M(-35.5%) | -$1.64 M(-50.8%) | -$19.24 M(-0.8%) |
| Sep 2007 | - | -$3.32 M(-51.1%) | -$19.39 M(-19.0%) |
| Jun 2007 | - | -$6.80 M(-9.2%) | -$23.93 M(-11.0%) |
| Mar 2007 | - | -$7.49 M(+320.3%) | -$26.89 M(-9.8%) |
| Dec 2006 | -$29.83 M(+53.8%) | -$1.78 M(-77.4%) | -$29.83 M(-19.9%) |
| Sep 2006 | - | -$7.87 M(-19.4%) | -$37.25 M(+5.6%) |
| Jun 2006 | - | -$9.76 M(-6.4%) | -$35.29 M(+44.8%) |
| Mar 2006 | - | -$10.42 M(+13.2%) | -$24.38 M(+25.7%) |
| Dec 2005 | -$19.39 M(+367.2%) | -$9.21 M(+55.8%) | -$19.39 M(+49.7%) |
| Sep 2005 | - | -$5.91 M(-609.8%) | -$12.95 M(+27.6%) |
| Jun 2005 | - | $1.16 M(-121.3%) | -$10.15 M(-20.2%) |
| Mar 2005 | - | -$5.43 M(+96.5%) | -$12.72 M(+206.6%) |
| Dec 2004 | -$4.15 M(-136.2%) | -$2.77 M(-11.2%) | -$4.15 M(-127.7%) |
| Sep 2004 | - | -$3.11 M(+120.2%) | $14.96 M(-17.2%) |
| Jun 2004 | - | -$1.41 M(-145.0%) | $18.07 M(+16.5%) |
| Mar 2004 | - | $3.14 M(-80.8%) | $15.52 M(+35.3%) |
| Dec 2003 | $11.47 M(+30.8%) | $16.35 M(>+9900.0%) | $11.47 M(-335.5%) |
| Sep 2003 | - | $0.00(-100.0%) | -$4.87 M(0.0%) |
| Jun 2003 | - | -$3.97 M(+338.3%) | -$4.87 M(+438.3%) |
| Mar 2003 | - | -$905.00 K(+201.7%) | -$905.00 K(+201.7%) |
| Dec 2002 | $8.77 M(-415.1%) | - | - |
| Dec 2001 | -$2.78 M(-50.5%) | - | - |
| Dec 2000 | -$5.62 M(+32.6%) | - | - |
| Dec 1999 | -$4.24 M(-48.2%) | - | - |
| Dec 1998 | -$8.19 M(-8.0%) | - | - |
| Mar 1998 | - | -$300.00 K(-160.0%) | -$300.00 K(-160.0%) |
| Dec 1997 | -$8.90 M(+111.9%) | - | - |
| Dec 1996 | -$4.20 M | - | - |
| Mar 1996 | - | $500.00 K | $500.00 K |
FAQ
- What is Avadel Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual CFO year-on-year change?
- What is Avadel Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly CFO year-on-year change?
- What is Avadel Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals TTM CFO year-on-year change?
What is Avadel Pharmaceuticals annual cash flow from operations?
The current annual CFO of AVDL is -$128.51 M
What is the all time high annual CFO for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual cash flow from operations is $84.29 M
What is Avadel Pharmaceuticals annual CFO year-on-year change?
Over the past year, AVDL annual cash flow from operations has changed by -$58.21 M (-82.79%)
What is Avadel Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of AVDL is -$6.89 M
What is the all time high quarterly CFO for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly cash flow from operations is $26.40 M
What is Avadel Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, AVDL quarterly cash flow from operations has changed by +$21.14 M (+75.42%)
What is Avadel Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of AVDL is -$82.81 M
What is the all time high TTM CFO for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high TTM cash flow from operations is $84.29 M
What is Avadel Pharmaceuticals TTM CFO year-on-year change?
Over the past year, AVDL TTM cash flow from operations has changed by +$45.70 M (+35.56%)